April 27, 2020 / 10:10 AM / a month ago

BRIEF-Amphastar Pharmaceuticals gets FDA Approval For Epinephrine Injection

April 27 (Reuters) - Amphastar Pharmaceuticals Inc:

* AMPHASTAR PHARMACEUTICALS, INC. RECEIVES FDA APPROVAL FOR EPINEPHRINE INJECTION, USP 30MG/30ML (1MG/ML) MULTIPLE DOSE VIAL

* AMPHASTAR PHARMACEUTICALS INC - GRANTED 180 DAY EXCLUSIVITY TO AMPHASTAR AS FIRST GENERIC FILER

* AMPHASTAR PHARMACEUTICALS INC - PLANS TO LAUNCH EPINEPHRINE INJECTION MULTIPLE DOSE VIAL WITHIN TWO TO THREE MONTHS

* AMPHASTAR PHARMACEUTICALS INC - FDA GRANTED 180 DAY EXCLUSIVITY TO AMPHASTAR AS FIRST GENERIC FILER

* AMPHASTAR PHARMACEUTICALS INC - PLANS TO LAUNCH EPINEPHRINE INJECTION MULTIPLE DOSE VIAL WITHIN TWO TO THREE MONTHS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below